Patheon completed it IPO
On Jul. 26, 2016, Patheon announced the closing of its initial public offering of 34,226,191 of its ordinary…
Agriculture | Biotechnology | Infectious Disease | Medicine | Pharmaceutical | Therapeutics | Vaccine
Texas A&M and iBio execute development agreement for plant-produced pharmaceuticals
On Jun. 7, 2016, IBio and the Texas A&M Institute of Infectious Animal Diseases (TAMUS) announced they had…
TEC Edmonton broke ground on newest technology accelerator with Merck Canada
On Sept. 5, 2017, business incubator TEC Edmonton announced a strategic partnership with Merck Canada to provide new…
Bioject Medical Technologies was acquired by Inovio Pharmaceuticals
On Mar. 14, 2016, Inovio Pharmaceuticals announced an agreement to acquire all of Bioject Medical Technologies’ assets including…
Biotechnology | Diagnostics | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Siteman and St. Louis Children’s Hospital established Siteman Kids at St Louis Children’s Hospital
In 2016, Siteman and St. Louis Children’s Hospital established Siteman Kids at St. Louis Children’s Hospital, focused on…
Biotechnology | CDC | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published updated ACIP recommendations regarding the intervals between PCV13 and PPSV23 vaccines
On Sept. 4, 2015, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
Biotechnology | Diagnostics | Medical Device | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics
Keck School of Medicine of USC established USC Alzheimer’s Therapeutic Research Institute
On Jun. 26, 2015, The Keck School of Medicine announced it had established the University of Southern California…
Biotechnology | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress
The NIH dedicated the Lowell P Weicker building
On May 4, 2015, the National Institutes of Health (NIH) dedicated Building 4 in honor of Lowell P….
Dendreon was acquired by Valeant Pharmaceuticals for $495 million
On Feb. 23, 2015, a bankruptcy judge approved the sale of the assets of Dendreon Corp., a Seattle-based…
Dr. Horace H. Loh received the SCBA Lifetime Achievement Award for his achievements and leadership in biochemical neuropharmacology
In 2015, Dr. Horace H. Loh received the Society of Chinese Bioscientists in America (SCBA) Lifetime Achievement Award…
Agriculture | Biotechnology | Chemistry | Diagnostics | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics | Veterinary
California Life Sciences Association was founded
In 2015, the California Life Sciences Association was founded. (CLSA) was founded when the Bay Area Bioscience Association…
BioCryst’s RAPIVAB(TM) (peramivir injection) received FDA approval for treatment of influenza in adults
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…
The North Carolina Eshelman School of Pharmacy received $100 million donation from Fred Eshelman
On Dec. 3, 2014, Fred Eshelman, CEO and founder of Wilmington-based PPD Inc. and a member of the…
Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at UBC
On Sept. 30, 2014, Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at the University…
Biotechnology | Disease | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published ACIP recommendations for use of PCV13 and PPSV23 vaccines in adults age 65 and older
On Sept. 19, 2014, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
Genentech announced a definitive agreement to acquire Seragon Pharmaceuticals
On Jul. 1, 2014, Genentech entered into an agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company…
Merck sold Sirna to Alnylam for $175 million
On Mar. 6, 2014, Merck announced that it had sold Sirna to Alnylam for $175 million. Sirna, orginally…
Illumina broke the ‘sound barrier’ of human genomics by enabling the $1,000 genome
On Jan 14, 2014, Illumina announced that it had broken the ‘sound barrier’ of human genomics by enabling…
Syntrix Biosystems won $115 million judgment in patent case against Illumina, the largest patent verdict in Washington state history
On Nov. 7, 2013 – Syntrix Biosystems announced a federal court in Tacoma, had granted the Auburn-based company…
Bend Research was acquired by Capsugel
On Oct. 1, 2013, Capsugel announced it had completed its acquisition of Bend Research. The company was founded…
Matrical Bioscience acquired by Brooks Automation for $10 million
On Jul. 23, 2013, Matrical Bioscience announced it has had been acquired by Chelmsford, Massachusetts-based Brooks Automation for…
The Priestley Medal was awarded to Peter J. Stang
On April 9, 2013, the American Chemical Society (ACS) awarded the Priestley Medal to Peter J. Stang “for…
Sanford Health acquired Hematech
On Jan. 4, 2013, Sanford Health announced the acquisition of Sioux Falls-based biotech company Hematech, a subsidiary of…
The CDC responded to the large fungal meningitis outbreak
On Nov. 15, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to the fungal meningitis…
Atossa Genetics completed its IPO
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
LigoCyte Pharmaceuticals was acquired Takeda Pharmaceutical
On Oct. 3, 2012, Takeda Pharmaceutical acquired LigoCyte for an upfront payment of $60 million, with future contingent…
Human Genome Sciences was acquired by GlaxoSmithKline for $3.6 billion
On Aug. 3, 2012, GlaxoSmithKline announced that it had completed its acquisition of Human Genome Sciences for $3.6…
Amnis Corp. was acquired by EMD Millipore
On Aug. 30, 2011, Amnis, a Seattle-based manufacturer of advanced cell imaging systems, announced the company had been…
Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks
On Aug. 17, 2011, researchers at the Stanford University School of Medicine announced they had paired up medicines…
Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million
On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…